Photo by yannym from unsplash
The definitive treatment for pyrrolizidine alkaloids (PAs)‐induced hepatic sinusoidal obstruction syndrome (HSOS) is not available. The effectiveness of anticoagulation therapy remains controversial. The efficacy of low molecular weight heparin (LMWH)… Click to show full abstract
The definitive treatment for pyrrolizidine alkaloids (PAs)‐induced hepatic sinusoidal obstruction syndrome (HSOS) is not available. The effectiveness of anticoagulation therapy remains controversial. The efficacy of low molecular weight heparin (LMWH) should be investigated in patients and animal models, and the underlying mechanism should be explored.
Keywords:
sinusoidal obstruction;
obstruction syndrome;
hepatic sinusoidal;
pyrrolizidine alkaloids;
induced hepatic
Journal Title: Liver International
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Liver International
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!